Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scales, Intervals, and Dissonance: Do Interpretations of Harmonized ACGME Milestone Levels Vary by User Role and Specialty?

Journal of graduate medical education·2026
Same author

Be SMART About Asthma Management: Single Maintenance and Reliever Therapy.

Journal of the American Board of Family Medicine : JABFM·2024
Same author

Revisiting our approach to behavioral health referrals.

The Journal of family practice·2023
Same author

Newer study shows smoking cessation aid is safe.

The Journal of family practice·2013
Same author

Drs. Hobbs and Mounsey respond.

The Journal of family practice·2013
Same author

PURLs: optimal timing for peripheral IV replacement?

The Journal of family practice·2013

Related Experiment Video

Updated: May 20, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Consider adding this drug to fight COPD that's severe.

Keia Hobbs, Dionna Brown

    The Journal of Family Practice
    |July 4, 2012
    PubMed
    Summary

    Daily azithromycin use, alongside standard COPD treatment, significantly lowers acute exacerbations in patients with moderate to severe chronic obstructive pulmonary disease. This finding offers a new therapeutic strategy for managing COPD flare-ups.

    Area of Science:

    • Pulmonology and Respiratory Medicine
    • Pharmacology and Therapeutics

    Background:

    • Chronic obstructive pulmonary disease (COPD) management often involves addressing acute exacerbations, which significantly impact patient morbidity and healthcare costs.
    • Current standard regimens for moderate to severe COPD may not fully prevent recurrent acute exacerbations.

    Discussion:

    • The study investigated the efficacy of daily azithromycin as an adjunct therapy in patients with moderate to severe COPD.
    • Azithromycin's anti-inflammatory and immunomodulatory properties may contribute to its prophylactic effect against exacerbations.

    Key Insights:

    • Daily azithromycin, when added to usual COPD care, demonstrated a reduction in the frequency of acute exacerbations.
    • This benefit was observed in patients with moderate to severe chronic obstructive pulmonary disease.

    More Related Videos

    Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
    04:24

    Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

    Published on: September 5, 2025

    Related Experiment Videos

    Last Updated: May 20, 2026

    Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
    04:03

    Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

    Published on: September 27, 2024

    Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
    04:24

    Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

    Published on: September 5, 2025

    Outlook:

    • Further research could explore optimal dosing, long-term safety, and patient-specific factors influencing azithromycin's effectiveness.
    • This approach may represent a valuable addition to the therapeutic armamentarium for preventing COPD exacerbations.